Bild and Handelsblatt wrote on Tuesday that the British Swedish AstraZeneca vaccine is only 8 percent effective in those over the age of 65. We also wrote the news and the drugmaker refuted it by mail, claimThere is no data set to support this claim and the UK Registry recommends dosing the same dose for patients over 65 years of age as it does in other age groups.
In the online edition of The Lancet last November Back Scientific evaluation of Phase 2 and 3 AstraZeneca vaccine studies. It states that local reactions, that is, mild, (such as redness, muscle pain, and local swelling) were recorded in 73 percent of the 56- to 69-year-olds tested and 61 percent of the 70-year-old group.
A common reaction to some test subjects also occurs to the vaccine, and it may be fever, rash, or other malaise.
Among those between the ages of 18 and 55, the effectiveness in screening for these symptoms was 86 percent, among those between the ages of 56 and 69 years, 77 percent, and among those over the age of 70, 65 percent.
It should be noted that the older the patient, the greater the chance that the body’s immune response will decrease, and this is also true in the tests. By the way, in vaccine developments, in many cases, vaccine testing is only carried out in phase IV over the age of 65. AstraZeneca also studied people over the age of 65 in Phases 2 and 3.
The studies were conducted between May 30 and August 8, 2020, on a sample of 560 people.
It is not yet known where the German papers obtained the information about the effectiveness of the AstraZeneca vaccine, but it can already be seen that the competition for vaccines is intensifying and it is part of the race. misinformation Also, this could also be the case here.